NEW YORK--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE:BMY) will announce results for the fourth quarter of 2018 on Thursday, January 24, 2019. During a conference call at 10:30 a.m. ET on January 24, company executives will review financial information and will address inquiries from investors and analysts.

Investors and the general public are invited to listen to a live webcast of the call at http://investor.bms.com or by dialing in the U.S. toll free 800-458-4121 or international 786-789-4772, confirmation code: 9368504. Materials related to the call will be available at the same website prior to the conference call. A replay of the call will be available beginning at 1:45 p.m. ET on January 24 through 1:45 p.m. ET on February 7, 2019. The replay will also be available through http://investor.bms.com or by dialing in the U.S. toll free 888-203-1112 or international 719-457-0820, confirmation code: 9368504.

About Bristol-Myers Squibb

Bristol-Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol-Myers Squibb, visit us at BMS.com or follow us on LinkedIn, Twitter, YouTube and Facebook.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181205005106/en/

Bristol-Myers Squibb Company

Media:
Carrie Fernandez
609-252-5222
carrie.fernandez@bms.com

Investors:
John Elicker
609-252-4611
john.elicker@bms.com

Tim Power
609-252-7509
timothy.power@bms.com

Bill Szablewski
609-252-5894
william.szablewski@bms.com

Source: Bristol-Myers Squibb Company